These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1533752)

  • 21. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.
    Loercher AE; Nash MA; Kavanagh JJ; Platsoucas CD; Freedman RS
    J Immunol; 1999 Dec; 163(11):6251-60. PubMed ID: 10570318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells are dysfunctional in patients with operable breast cancer.
    Satthaporn S; Robins A; Vassanasiri W; El-Sheemy M; Jibril JA; Clark D; Valerio D; Eremin O
    Cancer Immunol Immunother; 2004 Jun; 53(6):510-8. PubMed ID: 14740176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of monocyte counts and ex vivo and in vitro monocyte cytokine production after major surgical trauma.
    Franke A; Lante W; Kollig E; Markewitz A
    J Surg Res; 2009 Jun; 154(1):91-8. PubMed ID: 18952234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.
    Räsänen L; Hyöty H; Lehto M; Kallioniemi OP; Antonen J; Huupponen T; Karjalainen J; Leinikki P
    Clin Exp Immunol; 1988 Mar; 71(3):470-4. PubMed ID: 2968203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired autologous mixed lymphocyte reaction (AMLR) reactivity of peripheral blood T cell subsets in rheumatoid arthritis.
    Keystone EC; Poplonski L; Snow KM; Martell M
    Clin Exp Immunol; 1989 Nov; 78(2):184-8. PubMed ID: 12412746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
    Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
    J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2.
    Takada S; Ueda Y; Suzuki N; Murakawa Y; Hoshino T; Green I; Steinberg AD; Horwitz DA; Sakane T
    Eur J Immunol; 1985 Mar; 15(3):262-7. PubMed ID: 3156746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the tumor cell associated glycoconjugate (TCA) derived Kato III, human gastric cancer cells on autologous mixed lymphocyte reaction in patients with rheumatoid arthritis].
    Kashiwagi N; Ochi T
    Ryumachi; 1992 Jun; 32(3):206-14. PubMed ID: 1387980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further characterization of the autologous mixed lymphocyte reaction: induction of double negative gamma delta T lymphocytes.
    Kawamura M; Satoh T; Fujii N; Abo T; Rikiishi H; Kumagai K
    Cell Immunol; 1991 Apr; 133(2):468-83. PubMed ID: 1707765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction.
    Suzuki R; Suzuki S; Takahashi T; Kumagai K
    J Exp Med; 1986 Nov; 164(5):1682-99. PubMed ID: 2430045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DR antigens render interleukin-2-producer T lymphocytes sensitive to interleukin-1.
    Palacios R
    Scand J Immunol; 1981 Sep; 14(3):321-6. PubMed ID: 6173920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired autologous mixed-lymphocyte reaction of peripheral blood lymphocytes in adult periodontitis.
    Kimura S; Fujimoto N; Okada H
    Infect Immun; 1991 Dec; 59(12):4418-24. PubMed ID: 1834575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated CD4-positive T-lymphocytes and impaired cell-mediated immunity in patients with carcinoma of the urinary bladder with schistosomiasis.
    Raziuddin S; Shetty S; Ibrahim A; Patil K
    Cancer; 1990 Feb; 65(4):931-9. PubMed ID: 1688730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired generation of high-affinity interleukin-2 receptors in the autologous mixed lymphocyte reaction in rheumatoid arthritis.
    Akasu F; Poplonski L; Snow KM; Volpe R; Keystone EC
    Clin Immunol Immunopathol; 1992 May; 63(2):142-7. PubMed ID: 1535295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Defective autologous mixed lymphocyte reaction (AMLR) in gastric cancer patients].
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):63-9. PubMed ID: 2139091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous mixed lymphocyte reaction in man. XX. The cellular and molecular basis of deficient T-T AMLR in aging humans.
    Vayuvegula B; Shimizu M; Gupta S
    Clin Immunol Immunopathol; 1987 Sep; 44(3):364-70. PubMed ID: 2957134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defect of autologous mixed lymphocyte reaction and interleukin-2 in aged individuals.
    Canonica GW; Ciprandi G; Caria M; Dirienzo W; Shums A; Norton-Koger B; Fudenberg HH
    Mech Ageing Dev; 1985 Nov; 32(2-3):205-12. PubMed ID: 2935684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral T-cell lymphoma with unique immunologic features.
    Sheikha A; al-Janadi M; al-Saigh A; Malatani T; Raziuddin S
    Cancer; 1993 Feb; 71(3):831-8. PubMed ID: 8431865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.